Shmagin Martin E 4
4 · Urigen Pharmaceuticals, Inc. · Filed Jan 30, 2009
Insider Transaction Report
Form 4
Urigen Pharmaceuticals, Inc.UGRP.OB
Shmagin Martin E
DirectorChief Financial Officer
Transactions
- Purchase
Common Stock, $.001 Par Value
2009-01-27$0.09/sh+5,000$450→ 3,099,073 total - Purchase
Common Stock, $.001 Par Value
2009-01-28$0.12/sh+5,000$600→ 3,116,573 total - Purchase
Common Stock, $.001 Par Value
2009-01-28$0.11/sh+2,500$275→ 3,111,573 total - Purchase
Common Stock, $.001 Par Value
2009-01-27$0.10/sh+10,000$1,000→ 3,109,073 total - Purchase
Common Stock, $.001 Par Value
2009-01-28$0.14/sh+1,000$140→ 3,117,573 total - Purchase
Common Stock, $.001 Par Value
2009-01-28$0.15/sh+2,000$300→ 3,118,573 total